Evidence map›Paper›PMID 22864798›Full record

Trial reportAnnals of surgical oncology2012

The unique clinical characteristics of melanoma diagnosed in children.

Dale Han, Jonathan S Zager, Gang Han, Suroosh S Marzban, Christopher A Puleo, Amod A Sarnaik, Damon Reed, Jane L Messina, Vernon K Sondak

Abstract readClinical Trial
In one paragraph

Trial report in Annals of surgical oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Melanoma in Pediatric and Young Adult Patients.Current oncology reports · 2024
    Review
  5. Article
  6. Molecular imaging and radionuclide therapy · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Pediatric Melanoma: A 35-year Population-based Review.Plastic and reconstructive surgery. Global open · 2017
    Article
  14. A Case of Pediatric Melanoma: Treatment Considerations in Advanced Disease.Plastic and reconstructive surgery. Global open · 2015
    Article
  15. Long-term Survival after Metastatic Childhood Melanoma.Plastic and reconstructive surgery. Global open · 2014
    Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dale HanDepartment of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Jonathan S Zager
Gang Han
Suroosh S Marzban
Christopher A Puleo
Amod A Sarnaik
Damon Reed
Jane L Messina
Vernon K Sondak

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI KENNETH Lynn WRIGHT · 1998 to 2026
$93.5M
NCI NIH HHS P30 CA076292
6 · The paper itself

Abstract

backgroundStudies have demonstrated a higher rate of nodal metastases in melanoma of childhood, but there is controversy about the overall prognosis relative to adults. We describe a large single-institution experience with pediatric melanoma and assess prognostic characteristics.

methodsRetrospective review identified 126 patients diagnosed with melanoma at <21 years of age and referred for treatment from 1986 to 2011. Atypical lesions were excluded. Clinicopathologic characteristics were correlated with sentinel lymph node (SLN) status and outcomes.

resultsSLN biopsy was positive in 18 of 62 cases (29 %). Increasing Breslow thickness correlated with a positive SLN (p < 0.05). After a median follow-up of 5 years, there were 27 recurrences and 20 deaths. Positive SLN patients had significantly worse recurrence-free survival (RFS, p < 0.05) and significantly worse melanoma-specific survival (MSS, p = 0.05) compared with negative SLN patients. The 5-year RFS and MSS for positive SLN patients were 59.5 and 77.8 %, compared with 93.7 and 96.8 % for negative SLN patients. Recurrences and melanoma-related deaths were often seen beyond 5 years. No deaths have occurred in patients <12 years, but 9.1 % of patients 12-17 years and 17.2 % of patients 18-20 years died from melanoma (p = 0.291).

conclusionsChildren with melanoma have higher rates of SLN metastases (29 %) than adults with comparable melanomas. Despite the higher incidence of nodal metastases, survival is equal to or better than what is reported for adults. However, long-term follow-up is necessary in this population since recurrences and deaths are often seen beyond 5 years.

Indexed as

Sentinel Lymph Node BiopsyAdolescentAdultChildFemaleFollow-Up StudiesHumansLymphatic MetastasisMaleMelanomaNeoplasm Recurrence, LocalNeoplasm StagingPrognosisRetrospective StudiesRisk FactorsSkin Neoplasms

Identifiers

PMID22864798
PMCPMC4519977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.